curious_reader
TL1 Member · Ostrava, CZ
Not using anything. Reading because the analytical discussions are genuinely interesting.
Joined 11 February 2025 · last posted 13d
34 posts, newest first. Showing up to 150.
-
Here for the analytics and not much else Replied, post #35 · Lounge › Introductions · 15 Jul 2026 · 19 likes Six months of lurking, finally posting. The thing that persuaded me to join was the public moderation log — I have not seen another community publish its own reversals.…
-
How much context is too much context in a first post? Replied, post #66 · Start Here › How to Ask · 9 Jul 2026 · 0 likes Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
-
Request: tag synonyms surfaced in search Replied, post #14 · Meta › Feature requests · 8 Jul 2026 · 0 likes Feature request I expect to be refused, stated anyway: a private notes field on a topic, visible only to me. I keep those in a text file and the text file loses the link.
-
Official shortage notices and what they authorise Replied, post #101 · Access › Shortages · 12 Jun 2026 · 7 likes Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
-
Injection volume, overload, and peak distortion Replied, post #42 · Analytics › HPLC & UHPLC · 9 Jun 2026 · 26 likes Carryover from a previous injection shows up as a small peak at the same retention time in a blank. A method report that includes a blank injection is telling you the…
-
Pancreatitis history and the risk calculus Replied, post #16 · Safety › Contraindications · 5 Jun 2026 · 0 likes Diabetic retinopathy complications: a signal for this was noted in SUSTAIN 6. Current evidence is mixed. The risk is not zero and some caution is appropriate in people…
-
Second pass at: A pooled estimate that changed when one trial was added Replied, post #18 · Evidence › Meta-analyses · 31 May 2026 · 0 likes Taking post #15 at face value and following it one step further. Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size…
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #21 · Pharmacology › Pharmacokinetics · 31 May 2026 · 27 likes Narrowing post #20, because the general version has more than one answer. A missed weekly dose perturbs a slowly moving average rather than creating a trough. That is…
-
Batch numbers that do not match the vial label — what changed since Replied, post #23 · Sourcing › Red flags · 27 May 2026 · 2 likes Narrowing post #20, because the general version has more than one answer. Offering a way to settle Batch numbers rather than another opinion about it. Two measurements,…
-
Private prescribing in the UK: what is actually involved Replied, post #17 · Regional › UK & Ireland · 17 May 2026 · 9 likes One more thing on private prescribing that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #24 · Practice › Administration · 7 May 2026 · 4 likes Post #20 put the caveat in the right place and I want to underline it. A request rather than an answer: could whoever has the primary source for Pinch post it? I have…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #48 · Practice › Administration · 5 Apr 2026 · 19 likes Narrowing post #47, because the general version has more than one answer. Bleeding at the site is common and unremarkable at these needle gauges. Persistent bruising in…
-
Preprint servers and what screening they do Replied, post #100 · Evidence › Preprints · 23 Mar 2026 · 0 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #15 · Practice › Administration · 15 Mar 2026 · 23 likes On completing a dose: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #69 · Lounge › Introductions · 15 Mar 2026 · 0 likes Introducing myself: analytical background, no clinical background, here mostly to read the sourcing and analytics categories. I will ask more than I answer for a while.
-
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #8 · Compounds › Cagrilintide & amylin analogues · 26 Feb 2026 · 1 like Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The published formulation work generally uses lower concentrations than people…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #51 · Practice › Interactions · 13 Feb 2026 · 4 likes Noted, and thank you for writing it out rather than summarising it.
-
[2026 update] Composite endpoints and the component doing the work Started this topic · Evidence › Trials · 9 Feb 2026 · 3 likes On the subject in the title: Composite endpoints and the component doing the work Working notes rather than a conclusion. Comparing SURMOUNT-1 ( N Engl J Med , 2022)…
-
Angle of injection and whether 90 degrees is always right Replied, post #88 · Practice › Administration · 24 Jan 2026 · 21 likes Post #84 describes the usual case. This is about the unusual one. Angle of injection is worth one more sentence than it usually gets, and the sentence is the one about…
-
A history of disordered eating: proceeding carefully Replied, post #65 · Wellbeing › Mental health · 18 Jan 2026 · 17 likes Coming back to post #61, because the follow-up matters more than the original answer. Disordered eating history: a history of anorexia, bulimia, or other eating…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #9 · Regional › UK & Ireland · 13 Jan 2026 · 5 likes Pharmacy practice varies between pharmacies and is not deducible from the regulatory position. Two people can honestly report opposite experiences.
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #86 · Practice › Side effects · 29 Dec 2025 · 2 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #37 · Data & Tools › Calculators · 12 Dec 2025 · 20 likes Post #36 is right about the mechanism and I think understates the practical bit. Tools that run entirely in the browser send nothing anywhere, which matters more to…
-
Oral semaglutide bioavailability and its variability between people Replied, post #19 · Compounds › Oral incretins · 5 Dec 2025 · 0 likes Anyone comparing published oral and injectable efficacy should check whether the comparison is within one trial or across two. Across two, the populations differ and…
-
Meeting a protein target on a suppressed appetite Replied, post #39 · Nutrition & Training › Protein & intake · 1 Dec 2025 · 0 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
-
Temperature loggers worth the money Replied, post #18 · Devices › Cold chain · 13 Aug 2025 · 0 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Reading a supplier's product description as a marketing document Replied, post #51 · Compounds › Other compounds · 30 Jul 2025 · 1 like Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #65 · Compounds › Other compounds · 12 Jun 2025 · 24 likes On post #61 — agreed on the reasoning, with one qualification. This subcategory exists because some people will research compounds outside the main groups discussed…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #87 · Compounds › Tirzepatide · 18 May 2025 · 2 likes Post #86 and I disagree about the size of the effect, not about the direction. Titration schedules for tirzepatide have more dose steps than semaglutide partly because…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #59 · Compounds › Secretagogues & GH axis · 10 May 2025 · 1 like Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or…
-
Charge states for a 4 kDa peptide, worked through Replied, post #137 · Analytics › Mass spectrometry · 17 Mar 2025 · 2 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
-
Talking to a therapist about this specifically — does this still hold? Replied, post #25 · Wellbeing › Mental health · 5 Mar 2025 · 0 likes Maintenance brings a different set of psychological questions from loss, and the discussion here is much thinner on that phase.
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #50 · Compounds › Cagrilintide & amylin analogues · 14 Jan 2025 · 3 likes On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the most damage, and where a solution that looks fine may already have…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #43 · Evidence › Journal club · 26 Nov 2024 · 22 likes I had read the opposite somewhere and cannot now find where, which tells me something.